Maltese cannabis producer A2W has committed to investing around 2 million euros directly into the drug development project.
The facility will include a science and innovation centre.
The site will be based in Madrid, Spain.
In the final article of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses red light and near-infrared photoreceptors in cannabis cultivation.
In the second article of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of artificial lighting for cannabis cultivation.
In the first of this three-part series, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the use of lighting for improving cannabis yield.
Cellular Goods explores biotechnology and synthetic chemistry for sustainable production.
In this article, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the essential elements central to producing a successful crop.
In this article, Dr Gary Yates, chief scientific officer at PharmaSeeds, discusses the pros and cons of types of germplasm selection.
“One of the most defining events in the history of Earth is the emergence of photosynthetic organisms.”
In this article for PharmaSeeds, Ben Taub speaks to expert growers about the art versus the science of cannabis cultivation.
The facility has been completed ahead of schedule.
A look at the circadian rhythm and biological clock.
The project will see hemp utilised as a power source.
Gary Yates, chief scientific officer at PharmaSeeds, explores how licensed cannabis production has a likeness to a major biological principle.
In this article, Dr Gary Yates, chief scientific officer at Pharmaseeds, discusses the cannabis cultivation revolution.
The AQSE Growth Market listed company has now begun the first stage of its research programme.
Innovative UK company Hemspan Ltd is revolutionising the construction industry with hemp.
We won’t spam you
